Major Events:
1995-
Metformin becomes available in the United States. Metformin prevents glucose production in the liver.
Mid 1990's-
The hormone GLP-1 is discovered. GLP-1 will lead to new diabetic drugs that increase insulin secretion in response to sugars, some even increase the number of beta cells in the pancreas.
1996-
Acarbose becomes available in the United States. Acarbose is an alpha-glucosidase inhibitor which can slow the digestion of some carbohydrates.
Lispro is introduced as the world's fastest acting insulin by the Eli Lilly and Company.
Lispro is introduced as the world's fastest acting insulin by the Eli Lilly and Company.
1997-
FDA approves Troglitazone, the first drug in the class of thiazolidinedione drugs. This drug improves insulin sensitivity in muscle cells.
The terms type one and type two diabetes become accepted. "Insulin-dependent diabetes" and "non-insulin-dependent diabetes" become used less frequently.
The fasting glucose level for diagnosing diabetes is now 126mg/dl instead of 140mg/dl.
The terms type one and type two diabetes become accepted. "Insulin-dependent diabetes" and "non-insulin-dependent diabetes" become used less frequently.
The fasting glucose level for diagnosing diabetes is now 126mg/dl instead of 140mg/dl.
1998-
The drug Repaglinide is developed. Repaglinide is a meglitinide which simulate insulin secretion when glucose is present.
The United Kingdom Prospective Diabetes Study shows that people who have tight control of both their blood sugar and pressure levels reduce their risk of any complications. This understanding transforms the nature of diabetes care throughout the world.
The United Kingdom Prospective Diabetes Study shows that people who have tight control of both their blood sugar and pressure levels reduce their risk of any complications. This understanding transforms the nature of diabetes care throughout the world.
Acarbose (Oral Medication)-
Acarbose enters the market in 1996 as an Anti-diabetic drug. This drug is used to help treat type two diabetes, but does not cure the disease. Acarbose is taken and then becomes a starch blocker helping prolong the digestion of carbohydrates and starches. As the drug prolongs the digestion it also allows for the cells and responsive insulin within the blood stream to begin working.